Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)
Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Sep 24, 2019
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Multinodular and Vacuolating Neuronal Tumor (MVNT), which is a type of benign (non-cancerous) brain tumor. Researchers want to learn more about how to identify MVNT using advanced imaging techniques, especially when it can be confused with other similar conditions. The trial is currently recruiting participants, and anyone aged 18 or older who has had an MRI that suggests they might have MVNT could be eligible. To qualify, participants need to meet certain criteria based on their MRI results, such as having a specific appearance of the tumor.
If you decide to participate in this study, you will undergo imaging tests that can help doctors understand your condition better. It's important to know that pregnant or breastfeeding women and those with certain legal protections cannot join this trial. Participants will be fully informed about the study and must give their consent before taking part. This research aims to improve the diagnosis and understanding of MVNT, potentially leading to better care for patients with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 years old
- * Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT:
- Major criteria:
- • Multinodular aspect in cluster
- • High FLAIR hypersignal / T2
- Minor criteria:
- • Absence of mass effect
- • Hyposignal T1
- • Center of the lesion in hypsignal FLAIR or T1 hypersignal
- • Affiliate or beneficiary of a Social Security scheme
- • Having received informed information about the study and consenting to participate in the study
- Exclusion Criteria:
- • Patient benefiting from a legal protection measure
- • Pregnant or lactating woman
- • Contraindication to MRI
About Fondation Ophtalmologique Adolphe De Rothschild
The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pierre Bénite, , France
Bordeaux, , France
Rennes, , France
Rouen, , France
Paris, , France
Saint Herblain, , France
Toulouse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials